Tracy Hoang is an Early-career researcher with a desire to achieve a cancer-free world. Tracy has completed a PhD focussed on glioblastoma, the most aggressive form of brain cancer. Her research project investigated combining standard glioblastoma therapy with cell cycle checkpoint inhibitors to cause the accumulation of DNA damage in glioblastoma cells to trigger tumour cell death via apoptosis. Tracy's current role invovles understanding how the immune system interplays with cancer with particular interest in mesothelioma. Tracy has undertaken flow cytometry analysis of immune cell populations and has extensive experience with preclinical experiments including drug administration and imaging.